Eczema, also known as atopic dermatitis, is a chronic and itchy skin condition that is very common. It is most prevalent in children, but can occur at any age. Adult onset is also common, one doesn't have to have had it as a child to experience eczema in adulthood. For more information about the condition, see this link.
The Skin Centre is currently conducting one trial, and beginning another in May on the subject of eczema.
This trial is a randomised, double-blind, placebo-controlled scenario. It is a parallel group study evaluating the efficacy and safety of QAW039 in the treatment of patients with moderate to severe atopic dermatitis.
Upcoming: R668-AD-1224(Recruiting from May, 2014)
This upcoming trial is a randomised double-blind, placebo-controlled study to demonstrate the long term safety and efficacy of Dupilumab in adult patients with moderate to severe atopic dermatitis.
Contact us using the form below if you want to participate in these clinical trials